LUPRON Drug Patent Profile

✉ Email this page to a colleague

When do Lupron patents expire, and when can generic versions of Lupron launch?

Lupron is a drug marketed by Abbvie Endocrine Inc and is included in six NDAs. There are two patents protecting this drug.

The generic ingredient in LUPRON is leuprolide acetate. There are twenty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lupron

A generic version of LUPRON was approved as leuprolide acetate by SANDOZ on August 4^th, 1998.

Subscribe

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LUPRON?
What are the global sales for LUPRON?
What is Average Wholesale Price for LUPRON?

Summary for LUPRON

US Patents:	0
Applicants:	1
NDAs:	6
Raw Ingredient (Bulk) Api Vendors:	57
Clinical Trials:	134
Drug Prices:	Drug price information for LUPRON
DailyMed Link:	LUPRON at DailyMed

Drug patent expirations by year for LUPRON

Recent Clinical Trials for LUPRON

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
NRG Oncology	Phase 2
Prostate Cancer Foundation	Phase 2
Panbela Therapeutics	Phase 2

See all LUPRON clinical trials

US Patents and Regulatory Information for LUPRON

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie Endocrine Inc	LUPRON	leuprolide acetate	SOLUTION;SUBCUTANEOUS	019010-001	Apr 9, 1985		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Abbvie Endocrine Inc	LUPRON DEPOT-PED KIT	leuprolide acetate	POWDER;INTRAMUSCULAR	020263-009	Apr 14, 2023		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y			⤷ Subscribe
Abbvie Endocrine Inc	LUPRON DEPOT	leuprolide acetate	INJECTABLE;INJECTION	020517-002	May 30, 1997		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Abbvie Endocrine Inc	LUPRON DEPOT	leuprolide acetate	INJECTABLE;INJECTION	019732-001	Jan 26, 1989		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Abbvie Endocrine Inc	LUPRON DEPOT-PED KIT	leuprolide acetate	POWDER;INTRAMUSCULAR	020263-004	Apr 16, 1993		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Abbvie Endocrine Inc	LUPRON DEPOT	leuprolide acetate	INJECTABLE;INJECTION	020517-003	Jun 17, 2011		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LUPRON

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie Endocrine Inc	LUPRON	leuprolide acetate	SOLUTION;SUBCUTANEOUS	019010-001	Apr 9, 1985	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LUPRON

See the table below for patents covering LUPRON around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Bulgaria	60340		⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for LUPRON

Recent Clinical Trials for LUPRON

Make Better Decisions: Try a trial or see plans & pricing